Global Sleep Apnea Devices Market is estimated to value over USD $ 6 billion by 2026 end and is expected to register a CAGR of over 10% during the forecast period from 2019 to 2026.
With advancements in medical sciences and technology, life expectancy has increased and thus has led to the rise of the geriatric population. This is expected to drive the prevalence of Obstructive Sleep Apnea (OSA) and sleep apnea devices play a key role here which is anticipated to fuel the market growth. Heightened consciousness about sleep disorders, their remedies and precautionary measures, precise and early disease diagnosis, patient adherence, and rise in financial dispensability to allow healthcare expenditure is forecasted to accelerate the revenue growth.
With the rise in the geriatric population, the health complications also increase gradually thus demanding more healthcare facilities and aid. A decrease in the dimension of the upper airway lumen due to the rising age can cause OSA, thus fueling the market’s demand worldwide. According to the United Nations (UN), the global geriatric community was nearly 962 million and it is anticipated to foster and grow twice as much by 2050.
Sleep disorders are becoming increasingly prevalent as a disease, and the high frequency of this disease requires efficient diagnosis and treatment and these are some administrators elevating revenue growth of the sleep apnea devices market. The influx of technological improvements provisioning patient protection and convenience is anticipated to enhance treatment adherence, particularly in mature markets such as North America. One of the most developed markets, North America, is growing unboundedly owing to great product acceptance along with government initiatives directed at restraining healthcare expenditure. The shift from taxed healthcare services to patient value and care along with the availability of reimbursement are some of the factors driving regional growth.
Improper diagnosis along with the delay in the examination can lead to serious health risks. Prolonged sleep apnea doubles the mounting risk of additional complications such as hypertension, cardiac diseases, diabetes, and mental disorders which in turn raises the overall healthcare cost burden on the economy. Building awareness regarding the continued consequences of sleep apnea is foreseen to boost revenue growth over the forecast period.
The therapeutic devices segment constituted the largest and highest portion of the market during the forecast period and is projected to continue expansion and record growth at the highest CAGR. The important factors aiding this growth are the expanding pool of undiagnosed sleep apnea patients across the globe and the improving reimbursement of patient adherence for these devices. The preference of patients leads to increased global acceptance of oral appliances considering the high rate of non-compliance with PAP devices.
The sleep laboratories & hospital segment valued for the most substantial share of the market, while home care settings/individuals segment is predicted to develop at the highest CAGR during the forecast period. This tremendous expansion is expected to be motivated by administrators such as the soaring inclination for home sleep testing by both patients and private insurance companies, along with the favorable reimbursement scenario for home sleep testing.
Geographically, North America is forecasted to acquire the highest market share. This geographical advancement is fundamentally encouraged by the growing incidence of sleep disorders and heightened government and non-governmental initiatives to raise awareness of diagnosis and health. Several governments administer programs to raise awareness of healthy sleeping habits for individuals and physicians. The main players in the regional market invest an enormous amount of capital to create sleep apnea equipment that is technologically efficient, efficient and simple to use, thus promoting the market worldwide.
Recent Developments
The global market is always booming with new innovations. Brimming with the latest technological advancements integrated to enhance patient experience and provide seamless treatment encourage the global market and its growth. ResMed (US) introduced the AirFit N30i, the first top-of-head-connected nasal CPAP mask, across North America with the latest invented nasal cradle cushion that rests just under the wearer’s nose, providing extra comfort.
Koninklijke Philips (Netherlands) launched its Dream Family solution which constitutes a DreamWear mask, DreamStation PAP device, and DreamMapper patient engagement app. All of these innovations help boost the market, propagate the market as well as increase the viability of patient’s adopting it.
Request a Sample Report @https://www.futurewiseresearch.com/request-sample.aspx?id=2329&page=requestsample
Market Segmentation
By Type
• Therapeutic Devices
o Positive Airway Pressure Devices
o Automatic Positive Airway Pressure Devices
o Continuous Positive Airway Pressure Devices
o Bilevel Positive Airway Pressure Devices
• Facial Interfaces
• Masks
o Full-Face Masks
o Nasal Pillow Masks
o Nasal Masks
• Cushions
• Accessories
• Oral Appliances
o Mandibular Advancement Devices
o Tongue-Retaining Devices
• Adaptive Servo-Ventilators
• Other Therapeutic Devices
• Diagnostic Devices
o Polysomnography Devices
o Ambulatory PSG Devices
o Clinical PSG Devices
o Home Sleep Testing Devices
• Oximeters
o Fingertip Oximeters
o Handheld Oximeters
o Wrist-Worn Oximeters
o Tabletop Oximeters
• Actigraphy Systems
• Sleep Screening Devices
By End-User
• Sleep Laboratories & Hospitals
• Home Care Settings/Individuals
By Region
• Europe
• North America
• APAC
• Latin America
• Rest of World
Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=2329&page=askfordiscount
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
Major firms in the market are BMC Medical Co. Ltd; Braebon Medical Corporation; Nihon Kohden; Cadwell Laboratories; ResMed; ImThera Medical Inc.; Invacare Corporation; Fisher & Paykel Healthcare Limited; GE Healthcare; Curative Medical Inc.; Curative Medical Inc.; Philips Respironics; and Compumedics Limited.
FutureWise Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data points affecting market growth
Objectives of the Study:
• To provide an exhaustive analysis on the global sleep apnea market by product type, by end-user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary and Primary Research Methodology
2.1.1.1 Secondary Research
2.1.1.1.1 Key Data From Secondary Sources
2.1.1.2 Primary Research
2.1.1.2.1 Key Data From Primary Sources
2.1.1.2.2 Key Insights From Primary Sources
2.1.2 Market Size Estimation Methodology
2.2 Market Data Validation and Triangulation
2.3 Assumptions for the Study

3 Executive Summary
4 Premium Insights
4.1 Sleep Apnea Devices Market Overview
4.2 Sleep Apnea Devices Market, By Type, 2019 vs 2024 (USD Million)
4.3 Sleep Apnea Therapeutic Devices Market, By Type, 2019 vs 2024 (USD Million)
4.4 Sleep Apnea Devices Market Share, By End User (2019 vs 2024)
4.5 Geographical Snapshot of the Sleep Apnea Devices: Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Large Pool of Undiagnosed Sleep Apnea Patients
5.2.1.2 Growing Awareness About the Ill Effects of Untreated Sleep Apnea
5.2.1.3 Growing Usage of Oral Appliances
5.2.1.4 Technological Advancements in Sleep Apnea Devices
5.2.1.5 Considerable Venture Capital Funding
5.2.1.6 Increasing Number of Companies Venturing Into the Sleep Apnea and Oral Appliances Markets
5.2.2 Restraints
5.2.2.1 High Cost of CPAP Machines
5.2.2.2 Complex Referral Pathways and Long Waiting Periods
5.2.3 Opportunities
5.2.3.1 Growing Demand for Home Healthcare
5.2.3.2 Increasing Focus on Telemedicine and Mhealth (Mobile Health)
5.2.4 Challenges
5.2.4.1 Lack of Patient Compliance

6 Epidemiological Assessment of Sleep Apnea
6.1 Introduction
6.2 Epidemiological Assessment
6.3 Prescription Pattern Assessment
6.4 Adherence Assessment

7 Alternate Therapies for Sleep Apnea
7.1 Introduction
7.2 Expiratory Positive Airway Pressure
7.3 Hypoglossal Nerve Stimulation
7.4 Oral Pressure Therapy
7.5 Positional Therapy

8 Sleep Apnea Devices Market, By Type
8.1 Introduction
8.2 Therapeutic Devices
8.2.1 Positive Airway Pressure Devices
8.2.1.1 PAP Devices Dominate the Therapeutic Devices Market
8.2.1.1.1 Automatic Positive Airway Pressure Devices
8.2.1.1.2 Continuous Positive Airway Pressure Devices
8.2.1.1.3 Bilevel Positive Airway Pressure Devices
8.2.2 Facial Interfaces
8.2.2.1 Role of Facial Interfaces in Increasing CPAP Compliance is Expected to Drive Market Growth
8.2.2.1.1 Masks
8.2.2.1.1.1 Full-Face Masks
8.2.2.1.1.2 Nasal Pillow Masks
8.2.2.1.1.3 Nasal Masks
8.2.2.2 Cushions
8.2.3 Accessories
8.2.3.1 The Growth of the Accessories Segment is Tied to the Devices Market
8.2.4 Oral Appliances
8.2.4.1 Advantages of Oral Appliances, Such as Comfort and Small Size, Have Driven Their Use
8.2.4.1.1 Mandibular Advancement Devices
8.2.4.1.2 Tongue-Retaining Devices
8.2.5 Adaptive Servo-Ventilators
8.2.5.1 Studies Demonstrating the Significance of ASV in Improving Clinical Outcomes are Expected to Fuel Market Growth
8.2.6 Other Therapeutic Devices
8.3 Diagnostic Devices
8.3.1 Polysomnography Devices
8.3.1.1 PSG Tests are Considered the Gold Standard for the Diagnosis of Sleep-Related Breathing Disorders
8.3.1.1.1 Ambulatory PSG Devices
8.3.1.1.2 Clinical PSG Devices
8.3.2 Home Sleep Testing Devices
8.3.2.1 Cost-Effectiveness of Home-Based Sleep Tests Expected to Fuel the Growth of Home Sleep Testing Devices
8.3.3 Oximeters
8.3.3.1 Oximeters Help in Preoperative Monitoring and are Commonly Used in Clinics
8.3.3.1.1 Fingertip Oximeters
8.3.3.1.2 Handheld Oximeters
8.3.3.1.3 Wrist-Worn Oximeters
8.3.3.1.4 Tabletop Oximeters
8.3.4 Actigraphy Systems
8.3.4.1 Increasing Focus on Assessing Actimeter Performance Will Contribute to Market Growth
8.3.5 Sleep Screening Devices
8.3.5.1 Rising Preference for Home-Based Testing is Driving the Use of Sleep Screening Devices

9 Sleep Apnea Devices Market, By End User
9.1 Introduction
9.2 Sleep Laboratories & Hospitals
9.2.1 Increasing Number of Sleep Labs Globally to Drive the Growth of This End-User Segment
9.3 Home Care Settings/Individuals
9.3.1 Rise in Preference of Patients and Insurance Companies for Home-Based Sleep Tests is Expected to Fuel Market Growth

10 Sleep Apnea Devices Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 US Dominated the North American Sleep Apnea Devices Market in 2018
10.2.2 Canada
10.2.2.1 Rise in the Number of Grants Awarded to Research Organizations – A Major Factor Driving Market Growth in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 The Prevalence of OSA in Germany is Among the Highest in Europe
10.3.2 France
10.3.2.1 Rising Geriatric Population to Increase the Prevalence of Sleep Apnea in France
10.3.3 UK
10.3.3.1 Increasing Number of Awareness Initiatives to Support Market Growth in the UK
10.3.4 Italy
10.3.4.1 Government Initiatives for Improving Care for Sleep Apnea Patients to Drive Sleep Apnea Devices Market Growth in Italy
10.3.5 Spain
10.3.5.1 Initiatives By Regional Organizations to Support Market Growth in Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.1.1 Changing Reimbursement Scenario to Drive Market Growth in Japan
10.4.2 China
10.4.2.1 Growing Adult Obesity Rates to Increase the Prevalence of Sleep Apnea in China
10.4.3 Australia
10.4.3.1 Continuous Technological Advancements By Regional Players to Drive Market Growth in Australia
10.4.4 RoAPAC
10.5 Rest of the World
10.6 Latin America
10.6.1 Rising Obesity Rate to Increase the Prevalence of Sleep Apnea in Latam
10.7 Middle East and Africa
10.7.1 Low Awareness About Sleep Apnea to Restrain Market Growth in the Middle East and Africa

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.2.1 Introduction
11.3 Competitive Leadership Mapping
11.3.1 Visionary Leaders
11.3.2 Innovators
11.3.3 Dynamic Differentiators
11.3.4 Emerging Companies
11.4 Competitive Scenario
11.4.1 Product Launches
11.4.2 Acquisitions
11.4.3 Partnerships, Agreements, and Collaborations

12 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, FutureWise View)*
12.1 Resmed
12.2 Koninklijke Philips
12.3 Fisher & Paykel Healthcare
12.4 Somnomed
12.5 Oventus Medical
12.6 Compumedics
12.7 Löwenstein Medical
12.8 Drive Devilbiss Healthcare
12.9 BMC Medical
12.10 Braebon Medical Corporation
12.11 Whole You
12.12 Panthera Dental


Inquire further details about this report at: [email protected]

About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com